Science 37 — Culver City, California

Science 37 is a clinical research site located in Culver City, California, United States 90230.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

Science 37 has participated in 18 clinical trials with 5 currently active.

Therapeutic areas: Asthma, Prevention of Stroke or Systemic Embolism, Atrial Fibrillation.

Sponsors: Bond Avillion 2 Development LP, Bayer, Chugai Pharmaceutical.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Culver City

Browse all research sites in California · View every site in Culver City

• Southern California Hospital at Culver City / Southern California Hospital at Hollywood
• Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites
• Proscience Research Group
• Alkermes Investigational Site
• Clinical Site
• Research Site
• Science37
• Pfizer Investigational Site
• GSK Investigational Site
• Neurocrine Clinical Site
• CCT/Parexel

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Science 37?

Science 37 has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Science 37 conducted?

Science 37 has 18 clinical trials on record, with 5 currently active. Their work covers Asthma, Prevention of Stroke or Systemic Embolism, Atrial Fibrillation.

Is Science 37 accredited by Crixeo Clinical Trials?

Science 37 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Science 37?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.